Keyword: The Bill & Melinda Gates Foundation
The Gates Medical Research Institute will turn drug industry expertise on diseases that kill millions annually in low- and middle-income countries.
The extension puts Visterra back on the multifront path through the clinic it plotted out before its aborted IPO attempt.
The Bill & Melinda Gates Foundation is investing up to $40 million spur research into the use of TCR-based therapeutics to treat tuberculosis and HIV.
Lundbeck chief Schultz will lead Teva, former CDC director Frieden leads a new health project, Roivant named Eisai exec Waxman as general counsel.
Infectious disease specialist Arsanis has raised a solid chunk of cash as it picks up the Gates Foundation and Alphabet's GV as backers.
Intarcia has raised $206 million in a second close of its Series EE financing, with the Bill & Melinda Gates Foundation pitching in a $50 million investment and up to $90 million in potential milestones, the company announced on Thursday.
Sydney-based Atomo Diagnostics picked up AU$4.5 million ($3.5 million) in equity from a number of investors, including the Gates Foundation-backed Global Health Investment Fund.